News and events
Under the umbrella of EuroNanoMed III, the 8th Joint Transnational Call will be launched for funding multilateral innovative research projects on nanomedicine together with the European Commission under the ERA-NET Cofund mechanism.
EuroNanoMed has recently applied for an extension of its activities in Europe and beyond. The ENM III application has been positively evaluated and is currently undergoing the Grant Agreement Preparation phase with the Commission.
The ENM III consortium, reinforced with 12 new partners from Europe, Canada and Taiwan, is committed to foster the competiveness of European nanomedicine actors, taking into account recent changes in the landscape and new stakeholders and challenges, as identified in the Nanomedicine Strategic Research and Innovation Agenda.
Nanomedicine Translation Advisory Board propose an instrument that offers free advice and support to accelerate European Nanomedicine R&D projects.
Application have to be done before May 8th at http://www.nanomedtab.eu/?apply.
More information in the flyer (DOWNLOAD PDF).
The ETPN and the EuroNanoMed II ERA-NET publish the Nanomedicine Strategic Research and Innovation Agenda to provide the ecosystem with a concrete framework, including priorities for research, and a long term vision up to 2030 to foster the fruitful deployment of innovative Nanomedicine solutions intended for healthcare.